dHG-5 Exhibits Dual Efficacy of Anti-Metastatic and Anti-hypercoagulability inMice by Inhibiting Heparanase and Intrinsic Coagulation Pathway

dHG-5 suppressed metastasis and hypercoagulability through heparanase inhibition and selective action on the intrinsic coagulation pathway. These findings highlight dHG-5 as a promising dual-action therapeutic candidate for managing metastasis and cancer-associated thrombosis, offering a safer alternative to traditional anticoagulants.